Psychoactive drugs and metabolic disorders

Detalhes bibliográficos
Autor(a) principal: Teixeira Bezerra, Tainá Patrícia
Data de Publicação: 2023
Outros Autores: Fabrício, Alba Inêz Celestino Rezende, Minervino, Alfredo José, Santos, Roberto Mendes dos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Debates em Psiquiatria (Online)
Texto Completo: https://revistardp.org.br/revista/article/view/439
Resumo: Objective: The objective of this article is to promote a literature revision and an overview of evidence of the metabolic impacts of the use of psychotropic drugs on metabolic alterations. Methods: A descriptive review, including articles in English and Portuguese, was conducted in the Google Scholar and PubMed databases, using the following keywords: body weight, dyslipidemia, metabolic syndrome and antipsychotics, mood stabilizers and antidepressants on PubMed, and dyslipidemia, body weight , metabolic syndrome associated with antipsychotics, mood stabilizers and antidepressants on Google Scholar. Results: 46 articles were analyzed and 46 articles were included. The review revealed a large amount of evidence concerning body weight changes under psychotropic drugs use and the impact of antipsychotics on the main metabolic variables. However, controversies and scanty evidence regarding mood stabilizers in glycemic and dyslipidemic alterations, and especially about antidepressants in metabolic alterations, were noticed. Conclusions: It is concluded that the impact of psychotropic drugs on metabolic changes has great clinical relevance and is characterized as a challenge for modern psychopharmacology. These alterations, seen as possible side effects of such drugs, directly affect the patient's quality and life expectancy, therefore, deserving attention for success in psychiatric treatment and in the holistic health context.  
id ABP-2_ed8612874ba29c4a3ea74ccebe41babc
oai_identifier_str oai:ojs.emnuvens.com.br:article/439
network_acronym_str ABP-2
network_name_str Debates em Psiquiatria (Online)
repository_id_str
spelling Psychoactive drugs and metabolic disordersFármacos psicoactivos y cambios metabólicosPsicofármacos e alterações metabólicas substâncias psicotrópicasefeitos colaterais e reações adversas relacionadas a drogasefeitos colaterais metabólicos de drogas e substânciaspsychotropicsdrug-related side effects and adverse reactionsmetabolic side effects of drugs and substancespsicotrópicosefectos colaterales y reacciones adversas relacionados con medicamentosefectos metabólicos secundarios de drogas y sustanciasObjective: The objective of this article is to promote a literature revision and an overview of evidence of the metabolic impacts of the use of psychotropic drugs on metabolic alterations. Methods: A descriptive review, including articles in English and Portuguese, was conducted in the Google Scholar and PubMed databases, using the following keywords: body weight, dyslipidemia, metabolic syndrome and antipsychotics, mood stabilizers and antidepressants on PubMed, and dyslipidemia, body weight , metabolic syndrome associated with antipsychotics, mood stabilizers and antidepressants on Google Scholar. Results: 46 articles were analyzed and 46 articles were included. The review revealed a large amount of evidence concerning body weight changes under psychotropic drugs use and the impact of antipsychotics on the main metabolic variables. However, controversies and scanty evidence regarding mood stabilizers in glycemic and dyslipidemic alterations, and especially about antidepressants in metabolic alterations, were noticed. Conclusions: It is concluded that the impact of psychotropic drugs on metabolic changes has great clinical relevance and is characterized as a challenge for modern psychopharmacology. These alterations, seen as possible side effects of such drugs, directly affect the patient's quality and life expectancy, therefore, deserving attention for success in psychiatric treatment and in the holistic health context.  Objetivo: El objetivo de este artículo es promover una revisión de la literatura y una visión general de la evidencia sobre los impactos metabólicos del uso de drogas psicotrópicas en las alteraciones metabólicas. Métodos: Se realizó una revisión descriptiva, incluyendo artículos en inglés y portugués, en las bases de datos Google Scholar y PubMed, utilizando los siguientes contraseñas: peso corporal, dislipidemia, síndrome metabólico y antipsicóticos, estabilizadores del estado de ánimo y antidepresivos en PubMed, y dislipidemia, peso corporal, síndrome metabólico asociado a antipsicóticos, estabilizadores del estado de ánimo y antidepresivos en Google Scholar. Resultados: Se revisaron 46 artículos y se incluyeron 46 artículos. La revisión reveló una gran cantidad de pruebas sobre los cambios en el peso corporal bajo el uso de fármacos psicotrópicos y el impacto de los antipsicóticos en las variables metabólicas clave. Sin embargo, se observaron controversias y escasas pruebas sobre los estabilizadores del estado de ánimo en los cambios glucémicos y dislipidémicos, y especialmente sobre los antidepresivos en los cambios metabólicos. Conclusiones: Se concluye que el impacto de los psicofármacos en las alteraciones metabólicas tiene gran relevancia clínica y se caracteriza por ser un reto para la psicofarmacología moderna. Dichas alteraciones, vistas como posibles efectos secundarios de tales fármacos, afectan directamente la calidad y la esperanza de vida del paciente, por lo tanto, merecen atención para lograr el éxito en el tratamiento psiquiátrico y en el contexto de la salud holística.Objetivo: O objetivo deste artigo é promover uma revisão da literatura e uma visão geral das evidências dos impactos metabólicos do uso de drogas psicotrópicas sobre as alterações metabólicas. Métodos: Uma revisão descritiva, incluindo artigos em inglês e português, foi realizada nas bases de dados do Google Scholar e PubMed, usando as seguintes palavras-chaves:  peso corporal, dislipidemia, síndrome metabólica e antipsicóticos, estabilizadores do humor e antidepressivos no PubMed, e dislipidemia, peso corporal, síndrome metabólica associada a antipsicóticos, estabilizadores do humor e antidepressivos no Google Scholar. Resultados: Foram analisados 46 artigos e 46 artigos foram incluídos. A revisão revelou uma grande quantidade de evidências relativas às mudanças de peso corporal sob uso de drogas psicotrópicas e o impacto dos antipsicóticos sobre as principais variáveis metabólicas. Entretanto, foram notadas controvérsias e escassas evidências sobre estabilizadores de humor em alterações glicêmicas e dislipidêmicas, e especialmente sobre antidepressivos em alterações metabólicas. Conclusões: Conclui-se que o impacto das drogas psicotrópicas nas alterações metabólicas tem grande relevância clínica e é caracterizado como um desafio para a psicofarmacologia moderna. Tais alterações, vistas como possíveis efeitos colaterais de tais drogas, afetam diretamente a qualidade e a expectativa de vida do paciente, portanto, merecendo atenção para obtenção de sucesso no tratamento psiquiátrico e no contexto holístico de saúde.    Associação Brasileira de Psiquiatria2023-01-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-ReviewedRevisado por ParesAvaliado Pelos Paresapplication/pdfhttps://revistardp.org.br/revista/article/view/43910.25118/2763-9037.2023.v13.439Debates in Psychiatry; Vol. 13 (2023); 1-20Debates em Psiquiatria; Vol. 13 (2023); 1-20Debates em Psiquiatria; v. 13 (2023); 1-202763-90372236-918Xreponame:Debates em Psiquiatria (Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABPenghttps://revistardp.org.br/revista/article/view/439/384Copyright (c) 2023 Tainá Patrícia Teixeira Bezerra, Alba Inêz Celestino Rezende Fabrício, Alfredo José Minervino, Roberto Mendes dos Santoshttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessTeixeira Bezerra, Tainá PatríciaFabrício, Alba Inêz Celestino RezendeMinervino, Alfredo JoséSantos, Roberto Mendes dos2024-01-21T09:29:06Zoai:ojs.emnuvens.com.br:article/439Revistahttps://revistardp.org.br/revista/oaiPUBhttps://revistardp.org.br/revista/oairdp@abp.org.br2763-90372236-918Xopendoar:2024-01-21T09:29:06Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP)false
dc.title.none.fl_str_mv Psychoactive drugs and metabolic disorders
Fármacos psicoactivos y cambios metabólicos
Psicofármacos e alterações metabólicas
title Psychoactive drugs and metabolic disorders
spellingShingle Psychoactive drugs and metabolic disorders
Teixeira Bezerra, Tainá Patrícia
substâncias psicotrópicas
efeitos colaterais e reações adversas relacionadas a drogas
efeitos colaterais metabólicos de drogas e substâncias
psychotropics
drug-related side effects and adverse reactions
metabolic side effects of drugs and substances
psicotrópicos
efectos colaterales y reacciones adversas relacionados con medicamentos
efectos metabólicos secundarios de drogas y sustancias
title_short Psychoactive drugs and metabolic disorders
title_full Psychoactive drugs and metabolic disorders
title_fullStr Psychoactive drugs and metabolic disorders
title_full_unstemmed Psychoactive drugs and metabolic disorders
title_sort Psychoactive drugs and metabolic disorders
author Teixeira Bezerra, Tainá Patrícia
author_facet Teixeira Bezerra, Tainá Patrícia
Fabrício, Alba Inêz Celestino Rezende
Minervino, Alfredo José
Santos, Roberto Mendes dos
author_role author
author2 Fabrício, Alba Inêz Celestino Rezende
Minervino, Alfredo José
Santos, Roberto Mendes dos
author2_role author
author
author
dc.contributor.author.fl_str_mv Teixeira Bezerra, Tainá Patrícia
Fabrício, Alba Inêz Celestino Rezende
Minervino, Alfredo José
Santos, Roberto Mendes dos
dc.subject.por.fl_str_mv substâncias psicotrópicas
efeitos colaterais e reações adversas relacionadas a drogas
efeitos colaterais metabólicos de drogas e substâncias
psychotropics
drug-related side effects and adverse reactions
metabolic side effects of drugs and substances
psicotrópicos
efectos colaterales y reacciones adversas relacionados con medicamentos
efectos metabólicos secundarios de drogas y sustancias
topic substâncias psicotrópicas
efeitos colaterais e reações adversas relacionadas a drogas
efeitos colaterais metabólicos de drogas e substâncias
psychotropics
drug-related side effects and adverse reactions
metabolic side effects of drugs and substances
psicotrópicos
efectos colaterales y reacciones adversas relacionados con medicamentos
efectos metabólicos secundarios de drogas y sustancias
description Objective: The objective of this article is to promote a literature revision and an overview of evidence of the metabolic impacts of the use of psychotropic drugs on metabolic alterations. Methods: A descriptive review, including articles in English and Portuguese, was conducted in the Google Scholar and PubMed databases, using the following keywords: body weight, dyslipidemia, metabolic syndrome and antipsychotics, mood stabilizers and antidepressants on PubMed, and dyslipidemia, body weight , metabolic syndrome associated with antipsychotics, mood stabilizers and antidepressants on Google Scholar. Results: 46 articles were analyzed and 46 articles were included. The review revealed a large amount of evidence concerning body weight changes under psychotropic drugs use and the impact of antipsychotics on the main metabolic variables. However, controversies and scanty evidence regarding mood stabilizers in glycemic and dyslipidemic alterations, and especially about antidepressants in metabolic alterations, were noticed. Conclusions: It is concluded that the impact of psychotropic drugs on metabolic changes has great clinical relevance and is characterized as a challenge for modern psychopharmacology. These alterations, seen as possible side effects of such drugs, directly affect the patient's quality and life expectancy, therefore, deserving attention for success in psychiatric treatment and in the holistic health context.  
publishDate 2023
dc.date.none.fl_str_mv 2023-01-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-Reviewed
Revisado por Pares
Avaliado Pelos Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistardp.org.br/revista/article/view/439
10.25118/2763-9037.2023.v13.439
url https://revistardp.org.br/revista/article/view/439
identifier_str_mv 10.25118/2763-9037.2023.v13.439
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://revistardp.org.br/revista/article/view/439/384
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
dc.source.none.fl_str_mv Debates in Psychiatry; Vol. 13 (2023); 1-20
Debates em Psiquiatria; Vol. 13 (2023); 1-20
Debates em Psiquiatria; v. 13 (2023); 1-20
2763-9037
2236-918X
reponame:Debates em Psiquiatria (Online)
instname:Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
instname_str Associação Brasileira de Psiquiatria (ABP)
instacron_str ABP
institution ABP
reponame_str Debates em Psiquiatria (Online)
collection Debates em Psiquiatria (Online)
repository.name.fl_str_mv Debates em Psiquiatria (Online) - Associação Brasileira de Psiquiatria (ABP)
repository.mail.fl_str_mv rdp@abp.org.br
_version_ 1796798365389815808